Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.

  • Rochano-Ortiz, Antonio
  • San Sebastián-Jaraba, Irene
  • Zamora, Carmen
  • Simó, Carolina
  • García-Cañas, Virginia
  • Martínez-Albaladejo, Sacramento
  • Fernández-Gómez, María José
  • Marcos-Ríos, Daniel
  • Martínez-Núñez, Patricia
  • Martín-Lorenzo, Marta
  • Velho, Tiago R
  • Ruíz-Rodríguez, María Jesús
  • Leal-Zafra, Amanda
  • Gabandé-Rodríguez, Enrique
  • Martínez-Martínez, Sara
  • Guala, Andrea
  • Lorenzo, Óscar
  • Blanco-Colio, Luis Miguel
  • Martín-Ventura, José Luís
  • Álvarez-Llamas, Gloria
  • Aldamiz-Echevarría, Gonzalo
  • Teixidó-Tura, Gisela
  • Forteza, Alberto
  • Nistal, Juan Francisco
  • Redondo, Juan Miguel
  • Méndez-Barbero, Nerea
  • Mittelbrunn, María
  • Oller, Jorge
Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology. Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential. Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model. The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondria during T cell aging

  • Escrig-Larena, Jose Ignacio
  • Delgado-Pulido, Sandra
  • Mittelbrunn, María
Mitochondrial dysfunction is a hallmark of aging that contributes to inflammaging. It is characterized by alterations of the mitochondrial DNA, reduced respiratory capacity, decreased mitochondrial membrane potential and increased reactive oxygen species production. These primary alterations disrupt other interconnected and important mitochondrial-related processes such as metabolism, mitochondrial dynamics and biogenesis, mitophagy, calcium homeostasis or apoptosis. In this review, we gather the current knowledge about the different mitochondrial processes which are altered during aging, with special focus on their contribution to age-associated T cell dysfunction and inflammaging., Funding for this research was provided by: Ministerio de Ciencia, Innovación y Universidades (FPU20/04066) European Commission (H2020-EU.1.1) European Regional Development Fund European Research Council (ERC-2021-CoG 101044248) Comunidad de Madrid, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Old T cells pollute with mito-litter

  • Gómez de las Heras, Manuel M.
  • Mittelbrunn, María
The mysteries behind immune aging and its related inflammation are being unmasked. Jin et al. reveal that the defective turnover of damaged mitochondria in CD4+ T cells from older individuals results in the exacerbated secretion of mitochondrial DNA, which fuels inflammaging and impairs immune responses., The authors were supported by the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III (PI19/855), the European Regional Development Fund (ERDF) and the European Commission through H2020-EU.1.1, European Research Council grant ERC-2021-CoG-101044248-Let T Be, and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid. M.M.G.d.l.H. is supported by a FPU grant (FPU19/02576) from Ministerio de Ciencia, Innovación y Universidades (Spain). Funding for this research was provided by: Ministerio de Educación, Cultura y Deporte (FPU19/02576), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CD4 T cell therapy counteracts inflammaging and senescence by preserving gut barrier integrity

  • Gómez de las Heras, Manuel M.
  • Carrasco, Elisa
  • Pérez-Manrique, Mario
  • Inohara, Naohiro
  • Delgado-Pulido, Sandra
  • Fernández-Almeida, Álvaro
  • Gálvez-Castaño, María I.
  • Francos-Quijorna, Isaac
  • Simó, Carolina
  • García-Cañas, Virginia
  • Escrig-Larena, Jose Ignacio
  • Aranda, Juan Francisco
  • Soto-Heredero, Gonzalo
  • Gabandé-Rodríguez, Enrique
  • Blanco, Eva M.
  • Días-Almeida, Joyce
  • Núñez, Gabriel
  • Mittelbrunn, María
Healthy aging relies on a symbiotic host–microbiota relationship. The age-associated decline of the immune system can pose a threat in this delicate equilibrium. In this work, we investigated how the functional deterioration of T cells can impact host–microbiota symbiosis and gut barrier integrity and the implications of this deterioration for inflammaging, senescence, and health decline. Using the Tfamfl/flCd4 Cre mouse model, we found that T cell failure compromised gut immunity leading to a decrease in T follicular and regulatory T (Treg) cells and an accumulation of highly proinflammatory and cytotoxic T cells. These alterations were associated with intestinal barrier disruption and gut dysbiosis. Microbiota depletion or adoptive transfer of total CD4 T cells or a Treg cell–enriched pool prevented gut barrier dysfunction and mitigated premature inflammaging and senescence, ultimately enhancing healthspan in this mouse model. Thus, a competent CD4 T cell compartment is critical to ensure healthier aging by promoting host–microbiota mutualism and gut barrier integrity., This research was supported by European Research Council grant ERC-2021-CoG 101044248-Let T Be (M.M.), Comunidad de Madrid (Spain) grant Y2020/BIO-6350 NutriSION-CM synergy (E.C. and M.M.), Spanish Ministerio de Ciencia e Innovación grant PID2022-141169OB-I00 (M.M.), Comunidad de Madrid (Spain) – Universidad Autónoma de Madrid (UAM) grant SI4/PJI/2024-00166 (E.C.), NIH grant R01 DK095782 (G.N.), Ministerio de Ciencia, Innovación y Universidades (Spain) FPU grants FPU19/02576 (M.M.G.H.), FPU22/01192 (M.P.-M.), and FPU20/04066 (J.I.E.-L.), Comunidad de Madrid (Spain) PIPF grant PIPF-2022/SAL-GL-25208 (S.D.-P.), Universidad Autónoma de Madrid FPI-UAM grant (G.S.-H.), and Ministerio de Ciencia, Innovación y Universidades (Spain) Juan de la Cierva-Incorporación grants IJC2018-036850-I (E.G.-R.) and JC2020-044392-I(I.F.-Q.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response

  • Rochano-Ortiz, Antonio
  • Simó, Carolina
  • García-Cañas, Virginia
  • Gabandé-Rodríguez, Enrique
  • Mittelbrunn, María
  • Oller, Jorge
Rochano-Ortiz et al., [Background and aims]: Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology., [Methods]: Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential., [Results]: Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model., [Conclusions]: The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I) and grant from Spanish Ministerio de Ciencia e Innovación grant (PID2022-137730OA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, EU; granted by Fundación MERCK-FEDER ‘Investigación clínica en enfermedades raras 2022’, Marfan Spanish Association (SIMA, www.Marfan.es) and by ‘V-Ayudas Muévete por los que no pueden 2021’. Research in M.M.’s lab was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). European Research Council. M.M.-L., G.A.-L., and G.A.-E. are funded by Instituto de Salud Carlos III through the projects PI20/01103, PI23/00100, and CP22/00100 (co-funded by European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future’). J.L.M.-V. is supported by grant from Spanish Ministerio de Ciencia e Innovación (PID2022-136979OB-I00). L.M.B.-C. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII/FEDER PI22/00233). G.T.-T. and A.G. are supported by Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015). O.L. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI20/00923 Instituto Carlos III). J.F.N. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI21/00084 FIS) and a grant from Health Research Institute Valdecilla (INNVAL21/24). N.M-B. is supported by Spanish Health Ministry or Spanish Ministeiro de Sanidad (PI21/01126). M.J.F.-G. is supported by Spanish Health Ministry or Spanish Ministerio de Sanidad contract (FIS22/00140). J.M.R. has received funding from La Caixa Foundation (HR18-00068); Spanish Ministerio de Ciencia e Innovación grant PID2021-122388OB-100 funded by MCIN/AEI/10.13039/501100011033; and Instituto de Salud Carlos III (CIBER-CV CB16/11/00264); Fundació La Marató TV3 grant 202334-31, and Spanish Ministerio de Ciencia e Innovación contract FPI (BES-2016-077649) to M.J.R.-R. The CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO is a Severo Ochoa Centers of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Butyrate extends health and lifespan in mice with mitochondrial deficiency

  • Gabandé-Rodríguez, Enrique
  • Gómez de las Heras, Manuel M.
  • Ramírez-Ruiz de Erenchun, Pablo
  • Simó, Carolina
  • García-Cañas, Virginia
  • Inohara, Naohiro
  • Berenguer-López, Inés
  • Enríquez-Zarralanga, Violeta
  • Fernández-Almeida, Álvaro
  • Oller, Jorge
  • Soto-Heredero, Gonzalo
  • Carrasco, Elisa
  • Vázquez-Muñoz, Cristina
  • Delgado-Pulido, Sandra
  • Escrig-Larena, Jose Ignacio
  • Francos-Quijorna, Isaac
  • Justo-Méndez, Raquel
  • Aranda, Juan Francisco
  • Poulton, Joanna
  • Lechuga-Vieco, Ana Victoria
  • Enríquez, José Antonio
  • Núñez, Gabriel
  • Mittelbrunn, María
[Data availability] Ileum RNA-sequencing raw data, as well as microbiota 16S rRNA gene sequencing raw data, are publicly available via NCBI with BioProject numbers PRJNA1301342 and PRJNA1291203, respectively., Mitochondrial diseases progressively lead to multisystemic failure with treatment options remaining extremely limited. Here, to investigate strategies that alleviate mitochondrial dysfunction, we first generate a ubiquitous and tamoxifen-inducible knockout mouse model of mitochondrial transcription factor A (TFAM), a nuclear-encoded protein involved in mitochondrial DNA (mtDNA) maintenance — Tfamfl/flUbcCre-ERT2 (iTfamKO) mice. Systemic TFAM deficiency triggers mitochondrial decline in a myriad of tissues in adult mice. Consequently, iTfamKO mice manifest multiorgan dysfunction including lipodystrophy, sarcopenia, metabolic alterations, kidney failure, neurodegeneration, and locomotor dysregulation, which result in the premature death of these mice. Interestingly, iTfamKO mice display intestinal barrier disruption and gut dysbiosis, with diminished levels of microbiota-derived short-chain fatty acids (SCFAs), such as butyrate. Mice with a deficient proof-reading version of the mtDNA polymerase gamma (mtDNA-mutator mice) phenocopy the dysfunction of the intestinal barrier and bacterial dysbiosis with reduced levels of butyrate, suggesting that different mouse models of mitochondrial dysfunction share insufficient generation of butyrate. Transfer of microbiota from healthy control mice or administration of tributyrin, a butyrate precursor, delay multiple signs of multimorbidity, extending lifespan in iTfamKO mice. Mechanistically, butyrate supplementation recovers epigenetic histone acylation marks that are lost in the intestine of Tfam deficient mice. Overall, our findings highlight the relevance of preserving host-microbiota symbiosis in disorders related to mitochondrial dysfunction., We thank the Oxford Hospitals charity and Lily Foundation “Treatments for Mitochondrial Disease – 2019/20” (J.P.), Fundación Ramón Areces and MINECO through the Centers of Excellence Severo Ochoa Award, and CERCA Programme of the Generalitat de Catalunya (A.V.L.-V.). Funded by the European Union (M.M.). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This research was supported by a European Research Council grant ERC-2021-CoG 101044248-Let T Be (M.M.), Comunidad de Madrid (Spain) grant Y2020/BIO-6350 NutriSION-CM synergy (E.C. and M.M.), Spanish Ministerio de Ciencia e Innovación grant PID2022-141169OB-I00 (M.M.), Comunidad de Madrid (Spain) – Universidad Autónoma de Madrid (UAM) grant SI4/PJI/2024-00166 (E.C.), NIH grant R01 DK095782 (G.N.), Ministerio de Ciencia, Innovación y Universidades (Spain) FPU grants FPU19/02576 (M.M.G.H.), FPU24/02492 (P.R.-R.) and FPU20/04066 (J.I.E.-L.), Comunidad de Madrid (Spain) PIPF grant PIPF-2022/SAL-GL-25208 (S.D.-P.), Universidad Autónoma de Madrid FPI-UAM grant (G.S.-H.), and Ministerio de Ciencia, Innovación y Universidades (Spain) Juan de la Cierva-Incorporación grants IJC2018-036850-I (E.G.-R.) and JC2020-044392-I (I.F.-Q.)., Peer reviewed